Inflammation & Immune Diseases

Overview

Therapeutic candidates that aim to reduce and/or eliminate excessive inflammatory response that harms the host tissues/organs are often specifically designed to target a pathway of sequential host reactions to the causative agents. At PharmaLegacy, the scientists are versatile and familiar with the models in testing the efficacy and safety for the chosen candidates of various signal pathways.

We have collected and validated virtually all widely used industry protocol models available and work to meet international standards in both consistency and accuracy. Our animal models and established experimental procedures are validated according to proven industry benchmarks (validated by MNCs and against reference compounds).